Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-25.39%Return on Equity
VS
Market
Sector
Industry
History
$ 38.26Close
$ 18.32 - $ 49.05 52-Week Range
Ticker Information
Ticker
LENZCompany Name
LENZ THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLENZ THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LENZ - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 206.37M | $ -52.4M | -25.39% |
| 3/31/2025 | $ 192.01M | $ -47.74M | -24.86% |
| 12/31/2024 | $ 204.08M | $ -49.77M | -24.39% |
| 9/30/2024 | $ 215.28M | $ -60.03M | -27.89% |
| 6/30/2024 | $ 192.92M | $ -72.31M | -37.48% |
| 3/31/2024 | $ 198.17M | $ -117.36M | -59.23% |
| 12/31/2023 | $ 183.58M | $ -124.65M | -67.9% |
| 9/30/2023 | $ 204.02M | $ -126.33M | -61.92% |
| 6/30/2023 | $ 224.15M | $ -128.53M | -57.34% |
| 3/31/2023 | $ 276.22M | $ -99.15M | -35.9% |
Key Performance Insights, Last 5 Years
- LENZ THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, LENZ THERAPEUTICS INC's average ROE has been -36.76%.
- The median ROE for LENZ THERAPEUTICS INC during this period was -30.14%
- LENZ THERAPEUTICS INC reached its highest ROE over the past 5 years at -18.42%.
- The lowest ROE recorded by LENZ THERAPEUTICS INC in the same timeframe -67.9%
LENZ THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for LENZ THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -68.37M ] / Equity [ $ -65.41M ]
(=) ROE [ 0% ] LENZ - Return on Equity, Last 5 years
-67.9%
Minimum
Dec 31, 2023
-18.42%
Maximum
Dec 31, 2021
-36.76%
Average
-30.14%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |